Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies

Yuen KS, Ye ZW, Fung SY, Chan CP, Jin DY. SARS-CoV-2 and COVID-19: The most important research questions. Cell Biosci. 2020;10:40.

Article  PubMed  PubMed Central  Google Scholar 

Fodor A, Tiperciuc B, Login C, Orasan OH, Lazar AL, Buchman C, et al. Endothelial dysfunction, inflammation, and oxidative stress in COVID-19-mechanisms and therapeutic targets. Oxid Med Cell Longev. 2021;2021:8671713.

Article  PubMed  PubMed Central  Google Scholar 

Schnaubelt S, Oppenauer J, Tihanyi D, Mueller M, Maldonado-Gonzalez E, Zejnilovic S, et al. Arterial stiffness in acute COVID-19 and potential associations with clinical outcome. J Intern Med. 2021;290:437–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Libby P, Lüscher T. COVID-19 is, in the end, an endothelial disease. Eur Heart J. 2020;41:3038–44.

Article  CAS  PubMed  Google Scholar 

Mezoh G, Crowther NJ. Endothelial dysfunction as a primary consequence of SARS-CoV-2 Infection. Adv Exp Med Biol. 2021;1321:33–43.

Article  CAS  PubMed  Google Scholar 

Ambrosino P, Calcaterra IL, Mosella M, Formisano R, D’Anna SE, Bachetti T, et al. Endothelial dysfunction in COVID-19: a unifying mechanism and a potential therapeutic target. Biomedicines. 2022;10:812.

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Rooij L, Becker LM, Carmeliet P. A role for the vascular endothelium in post-acute COVID-19? Circulation. 2022;145:1503–5.

Article  PubMed  Google Scholar 

Gladka MM, Maack C. The endothelium as Achilles’ heel in COVID-19 patients. Cardiovasc Res. 2020;116:e195–e7.

Article  CAS  PubMed  Google Scholar 

Lowenstein CJ, Solomon SD. Severe COVID-19 is a microvascular disease. Circulation. 2020;142:1609–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma Z, Yang KY, Huang Y, Lui KO. Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications. J Mol Cell Cardiol. 2021;164:69–82.

Article  PubMed  PubMed Central  Google Scholar 

Flaumenhaft R, Enjyoji K, Schmaier AA. Vasculopathy in COVID-19. Blood. 2022;140:222–35.

Article  CAS  PubMed  Google Scholar 

Basta G. Direct or indirect endothelial damage? An unresolved question. EBioMedicine. 2021;64:103215.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kandhaya-Pillai R, Yang X, Tchkonia T, Martin GM, Kirkland JL, Oshima J. TNF-α/IFN-γ synergy amplifies senescence-associated inflammation and SARS-CoV-2 receptor expression via hyper-activated JAK/STAT1. Aging Cell. 2022;21:e13646.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nägele MP, Haubner B, Tanner FC, Ruschitzka F, Flammer AJ. Endothelial dysfunction in COVID-19: Current findings and therapeutic implications. Atherosclerosis. 2020;314:58–62.

Article  PubMed  PubMed Central  Google Scholar 

Xu S, Ilyas I, Little PJ, Li H, Kamato D, Zheng X, et al. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies. Pharmacol Rev. 2021;73:924–67.

Article  CAS  PubMed  Google Scholar 

Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017–32.

Article  CAS  PubMed  Google Scholar 

Villar J, Kacmarek RM. The American-European Consensus Conference definition of the acute respiratory distress syndrome is dead, long live positive end-expiratory pressure! Med Intensiv. 2012;36:571–5.

Article  CAS  Google Scholar 

Hussain M, Khurram Syed S, Fatima M, Shaukat S, Saadullah M, Alqahtani AM, et al. Acute respiratory distress syndrome and COVID-19: a literature review. J Inflamm Res. 2021;14:7225–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Filbin MR. Insights into endotheliopathy in COVID-19. Am J Respir Crit Care Med. 2022. https://doi.org/10.1164/rccm.202207-1258ED.

Six I, Guillaume N, Jacob V, Mentaverri R, Kamel S, Boullier A, et al. The endothelium and COVID-19: an increasingly clear link brief title: endotheliopathy in COVID-19. Int J Mol Sci. 2022;23:6196.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amraei R, Yin W, Napoleon MA, Suder EL, Berrigan J, Zhao Q, et al. CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2. ACS Cent Sci. 2021;7:1156–65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Colunga Biancatelli RML, Solopov PA, Sharlow ER, Lazo JS, Marik PE, Catravas JD. The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in Κ18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2021;321:L477–l84.

Article  PubMed  PubMed Central  Google Scholar 

Joffre J, Rodriguez L, Matthay ZA, Lloyd E, Fields AT, Bainton RJ, et al. COVID-19-Associated lung microvascular endotheliopathy: a “from the bench” perspective. Am J Respir Crit Care Med. 2022. https://doi.org/10.1164/rccm.202107-1774OC.

Ashour L. Roles of the ACE/Ang II/AT1R pathway, cytokine release, and alteration of tight junctions in COVID-19 pathogenesis. Tissue Barriers. 2022; 2090792. https://doi.org/10.1080/21688370.2022.2090792.

Vassiliou AG, Kotanidou A, Dimopoulou I, Orfanos SE. Endothelial damage in acute respiratory distress syndrome. Int J Mol Sci. 2020;21:8793.

Article  CAS  PubMed Central  Google Scholar 

Liu Y, Zhang HG. Vigilance on new-onset atherosclerosis following SARS-CoV-2 infection. Front Med. 2020;7:629413.

Article  Google Scholar 

Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116:1666–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen L, Li X, Chen M, Feng Y, Xiong C. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020;116:1097–100.

Article  CAS  PubMed  Google Scholar 

Katsoularis I, Fonseca-Rodríguez O, Farrington P, Lindmark K, Fors Connolly AM. Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet (Lond, Engl). 2021;398:599–607.

Article  CAS  Google Scholar 

Fardman A, Zahger D, Orvin K, Oren D, Kofman N, Mohsen J, et al. Acute myocardial infarction in the Covid-19 era: Incidence, clinical characteristics and in-hospital outcomes-A multicenter registry. PLoS One. 2021;16:e0253524.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Toscano O, Cosentino N, Campodonico J, Bartorelli AL, Marenzi G. Acute myocardial infarction during the COVID-19 pandemic: an update on clinical characteristics and outcomes. Front Cardiovasc Med. 2021;8:648290.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aye YN, Mai AS, Zhang A, Lim OZH, Lin N, Ng CH, et al. Acute myocardial infarction and myocarditis following COVID-19 vaccination. QJM. 2021. https://doi.org/10.1093/qjmed/hcab252.

Kondo Y, Larabee JL, Gao L, Shi H, Shao B, Hoover CM, et al. L-SIGN is a receptor on liver sinusoidal endothelial cells for SARS-CoV-2 virus. JCI insight. 2021;6:e148999.

Article  PubMed Central  Google Scholar 

Saviano A, Baumert TF. Unraveling the role of liver sinusoidal endothelial cells in COVID-19 liver injury. J Hepatol. 2021;75:503–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McConnell MJ, Kawaguchi N, Kondo R, Sonzogni A, Licini L, Valle C, et al. Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy. J Hepatol. 2021;75:647–58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jothimani D, Venugopal R, Abedin MF, Kaliamoorthy I, Rela M. COVID-19 and the liver. J Hepatol. 2020;73:1231–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alexander MP, Mangalaparthi KK, Madugundu AK, Moyer AM, Adam BA, Mengel M, et al. Acute kidney injury in severe COVID-19 has similarities to sepsis-associated kidney injury: a multi-omics study. Mayo Clin Proc. 2021;96:2561–75.

Article  CAS  PubMed  Google Scholar 

Henry BM, de Oliveira MHS, Cheruiyot I, Benoit JL, Cooper DS, Lippi G, et al. Circulating level of Angiopoietin-2 is associated with acute kidney injury in coronavirus disease 2019 (COVID-19). Angiogenesis. 2021;24:403–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Poloni TE, Medici V, Moretti M, Visonà SD, Cirrincione A, Carlos AF, et al. COVID-19-related neuropathology and microglial activation in elderly with and without dementia. Brain Pathol (Zur, Switz). 2021;31:e12997.

留言 (0)

沒有登入
gif